Pictet Asset Management (Switzerland)’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-403,136
Closed -$5.84M 1584
2022
Q2
$5.84M Sell
403,136
-7,287
-2% -$124K 0.01% 725
2022
Q1
$10.7M Sell
410,423
-15,427
-4% -$438K 0.01% 634
2021
Q4
$16.9M Sell
425,850
-7,102
-2% -$324K 0.02% 554
2021
Q3
$21.7M Buy
+432,952
New +$23.6M 0.02% 495

Other funds holding HCAT

Pictet Asset Management (Switzerland)'s HCAT Position: Q3 2022 in Review

Pictet Asset Management (Switzerland) sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 403,136 shares — an estimated $5.84M sold.

Pictet Asset Management (Switzerland) first reported a position in HCAT in Q3 2021 and held it in 4 quarters. The position peaked at $21.7M in Q3 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

  • Pictet Asset Management (Switzerland) reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 403,136 Health Catalyst shares in Q3 2022, an estimated $5.84M.
  • Pictet Asset Management (Switzerland) first reported a position in Health Catalyst in Q3 2021 and held it in 4 quarters.
  • Pictet Asset Management (Switzerland)'s Health Catalyst position peaked at $21.7M in Q3 2021.
  • 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.